Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Some information within reports including certain batch identifiers may be redacted
Ethics declarations Ethics Approval and Consent to Participate Written informed consent was obtained from all individual participants included in the study
Most clinical guidelines consider a meaningful trial to be at least three to six months at the therapeutic dose, with appropriate lifestyle support
Retatrutide : GI adverse events dose-dependent
Phase 2 weight loss (48 weeks): 17.1% at 4 mg maintenance 8 mg Weeks 912 Strong therapeutic dose with substantial appetite suppression and metabolic improvements
US$ 23.95
US$ 23.51
US$ 20.11
US$ 27.14
US$ 20.12
